GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

Elon Musk has dished the secrets behind his recent weight loss transformation.

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

“These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a ...

The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.